Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-12-24 | Paul Kinnon, President and Chief Executive Officer, Director. Mr. Kinnon was appointed to the Board and appointed our President and Chief Executive Officer on September 30, 2013. Compensation table shows $939,225 grant date fair value of awards. |
| 2015-04-30 | Paul Kinnon, President, Chief Executive Officer and Interim Chief Financial Officer of Transgenomic, Inc. Directors who are our employees did not receive compensation for serving on the Board or its committees in fiscal 2014. |
| 2016-04-29 | Paul Kinnon. Mr. Kinnon has served as our President and Chief Executive Officer and a Director since September 2013. On October 31, 2014, Mr. Kinnon was appointed Interim Chief Financial Officer... Directors who are our employees did not receive compensation for serving on the Board or its committees in fiscal 2015. |
| 2016-09-22 | Paul Kinnon, President, Chief Executive Officer, Interim Chief Financial Officer and Director |
| 2017-12-29 | Paul Kinnon, former Chief Executive Officer and Director (1) Mr. Kinnon resigned from the Company effective June 29, 2017. |
Data sourced from SEC filings. Last updated: 2026-03-05